VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 55 filers reported holding VERSARTIS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $3,397,000 | -30.9% | 2,426,310 | 0.0% | 0.02% | -40.5% |
Q2 2018 | $4,913,000 | +108.8% | 2,426,310 | +70.1% | 0.04% | +85.0% |
Q1 2018 | $2,353,000 | -25.0% | 1,426,310 | 0.0% | 0.02% | -25.9% |
Q4 2017 | $3,138,000 | -10.9% | 1,426,310 | -0.8% | 0.03% | -6.9% |
Q3 2017 | $3,521,000 | -87.8% | 1,437,214 | -13.5% | 0.03% | -88.5% |
Q2 2017 | $28,977,000 | -18.3% | 1,660,593 | 0.0% | 0.25% | -12.8% |
Q1 2017 | $35,454,000 | +23.9% | 1,660,593 | -13.5% | 0.29% | +3.2% |
Q4 2016 | $28,621,000 | +9.5% | 1,920,845 | -10.0% | 0.28% | +18.6% |
Q3 2016 | $26,145,000 | -13.2% | 2,134,247 | -21.6% | 0.24% | -25.0% |
Q2 2016 | $30,121,000 | +17.4% | 2,723,399 | -14.9% | 0.32% | +16.6% |
Q1 2016 | $25,660,000 | -36.1% | 3,199,559 | -1.3% | 0.27% | -18.6% |
Q4 2015 | $40,166,000 | +7.5% | 3,241,783 | 0.0% | 0.33% | -3.5% |
Q3 2015 | $37,378,000 | -28.5% | 3,241,783 | -5.7% | 0.34% | -24.8% |
Q2 2015 | $52,305,000 | -4.4% | 3,436,585 | +15.4% | 0.46% | +0.9% |
Q1 2015 | $54,694,000 | +6.8% | 2,977,396 | +30.5% | 0.46% | -13.0% |
Q4 2014 | $51,225,000 | +116.5% | 2,281,744 | +83.1% | 0.52% | +75.5% |
Q3 2014 | $23,663,000 | -32.3% | 1,246,089 | +0.0% | 0.30% | -30.4% |
Q2 2014 | $34,935,000 | – | 1,245,889 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
RA Capital Management | 231,267 | $5,192,000 | 0.56% |
Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |